Aldeyra Therapeutics, Inc. (ALDX)
NASDAQ: ALDX · Real-Time Price · USD
6.17
-0.51 (-7.57%)
Mar 31, 2025, 12:51 PM EDT - Market open

Aldeyra Therapeutics Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2019 - 2015
Period Ending
Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2019 - 2015
Net Income
-55.85-37.54-62.02-57.78-37.55
Upgrade
Depreciation & Amortization
0.250.260.260.260.06
Upgrade
Asset Writedown & Restructuring Costs
----1.75
Upgrade
Loss (Gain) From Sale of Investments
-1.67-0.01-0.05--0.09
Upgrade
Stock-Based Compensation
7.975.758.297.117.08
Upgrade
Other Operating Activities
0.180.350.330.410.09
Upgrade
Change in Accounts Payable
-1.161.2-0.890.64-0.43
Upgrade
Change in Unearned Revenue
-6---
Upgrade
Change in Other Net Operating Assets
7.07-6.34-2.566.8-8.4
Upgrade
Operating Cash Flow
-43.21-30.33-56.64-42.56-37.49
Upgrade
Capital Expenditures
---0.02-0.01-
Upgrade
Investment in Securities
-44.9230-29.94-29.02
Upgrade
Investing Cash Flow
-44.9230-29.95-0.0129.02
Upgrade
Long-Term Debt Repaid
-0.29-1.04---
Upgrade
Total Debt Repaid
-0.29-1.04---
Upgrade
Net Debt Issued (Repaid)
-0.29-1.04---
Upgrade
Issuance of Common Stock
0.390.311.22194.541.9
Upgrade
Repurchase of Common Stock
--0.53---
Upgrade
Other Financing Activities
-0.27----
Upgrade
Financing Cash Flow
-0.17-1.271.22194.541.9
Upgrade
Net Cash Flow
-88.3-1.6-85.37151.9333.43
Upgrade
Free Cash Flow
-43.21-30.33-56.65-42.56-37.49
Upgrade
Free Cash Flow Per Share
-0.73-0.51-0.97-0.79-1.10
Upgrade
Cash Interest Paid
1.751.71.341.341.39
Upgrade
Levered Free Cash Flow
-17.06-27.6292.19-123.6-20.28
Upgrade
Unlevered Free Cash Flow
-15.86-26.3293.25-122.51-19.09
Upgrade
Change in Net Working Capital
-13.495.59-123.994.734.56
Upgrade
Updated Feb 28, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q